investors

investors

Slack Capital interview: Damien Perriman, CCO

55 views May 19, 2025

Last week, Slack Capital - an Australian investment research publication - has released an...

investors

Slack Capital interview: Damien Perriman, CCO...

20 views May 19, 2025

Last week, Slack Capital - an Australian investment research publication - has released an...

investors

Slack Capital interview: Tyler Korman, VP of...

36 views May 10, 2025

This week, Slack Capital - an Australian investment research publication - has released an...

investors

eXoZymes launches subsidiary, NCTx, to unlock a...

159 views May 06, 2025

At the yearly SynBioBeta conference, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of...

investors

AI transforming biotechnology: From form with...

112 views April 28, 2025

Co-founder and VP of Development at eXoZymes, Dr. Paul Opgenorth, states: "The Large Language...

investors

Introducing our new CCO: Damien Perriman

64 views March 28, 2025

Our new Chief Commercial Officer, Damien Perriman, brings more than two decades of experience in...

investors

CNBC closing bell footage from Feb 19, 2025

35 views February 21, 2025

Part of the coverage of eXoZymes’ closing bell ceremony on Feb 19, 2025 from CNBC. Credit: CNBC...

investors

Nasdaq: eXoZymes CEO Michael Heltzen's closing...

56 views February 20, 2025

This Michael Heltzen's (CEO of eXoZymes) closing bell speech from February 19, 2025, when...

investors

Looking at the rest of 2025 - part 4 of a...

91 views February 10, 2025

In this video - recorded on Dec 29, 2024 - MDB Capital Group’s Lou Basenese interviews Invizyne...

investors

Go To Market Strategy - part 3 of a fireside...

138 views January 15, 2025

In this video - recorded on Dec 29, 2024 - MDB Capital Group’s Lou Basenese interviews Invizyne...